Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- NAFLD: An Emerging Epidemic with No Approved Treatment
-
- 8 Recent FDA Updates in Gastroenterology
- FDA Approves Orbera Intragastric Balloon for Weight Loss in Obese Adults
- FDA Grants Fast Track Designation to CEQ508 for Familial Adenomatous Polyposis
- Tackling the Epidemic of Fatty Liver Disease
- HCV VOICE II: Optimizing Virological Outcomes with Integrated HCV Education
- AASLD/IDSA Release Updated HCV Treatment Guidelines
- FDA Issues Draft Guidance on Nonproprietary Naming of Biologics, Biosimilars
- Data Insufficient for Recommending Anti-TNF Discontinuation in IBD Remission
-
- Data, While Promising, Insufficient for Recommending Elimination Diets in IBS
- Early Response to Remicade Predicts Long-term Benefit in Patients with Ulcerative Colitis
- Kuvan Fails to Improve Portal Hypertension in Patients with Cirrhosis
- Microbiome Composition Associated with Efficacy of Low FODMAP Diet in Pediatric IBS
- Olysio/Sovaldi Combo Yields High SVR in HCV With Advanced Cirrhosis
- Patients With Celiac Disease Have Slight Increased Risk for EoE
- Study Shows Caffeine Decreases Risk of Hepatic Fibrosis in Male HCV Patients
- Study Supports CDC Recommendation to Suspend Annual FOBT After Negative Colonoscopy
-
- Thalomid Induces, Maintains Remission in Refractory Pediatric UC
- AGA Proposes Recertification Process Based on Active Learning
- ASGE Task Force: New Endoscopic Bariatric Therapies Effective for Treating Obesity
- FDA Issues Warning Letters to Duodenoscope Manufacturers Following ‘Superbug’ Outbreaks
- NICE Supports Adoption of Infliximab Biosimilar With New Resource